Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02990520 · ClinicalTrials.gov registry record
Prevalence of Malnutrition and/or Sarcopenia at Hospital Admission
A clinical trial, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- 190
- Enrollment target
NCT02990520: Completed study, sponsored by The University of Texas Medical Branch, Galveston.
NCT02990520 is a clinical trial that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 190 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02990520 has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- 190 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the prevalence of malnutrition and/or sarcopenia at admission to the hospital in older adults.
Primary Outcome
malnutrition measured with questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2015-02 |
| Est. Completion | 2024-02-02 |
What the finished NCT02990520 record still lists
NCT02990520 is an observational study that tracks outcomes without assigning an intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02990520 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02990520 about?
NCT02990520 is a clinical study titled "Prevalence of Malnutrition and/or Sarcopenia at Hospital Admission". The purpose of this study is to determine the prevalence of malnutrition and/or sarcopenia at admission to the hospital in older adults.
What is the current status of trial NCT02990520?
This trial is currently completed. The enrollment target is 190 participants. The study started on 2015-02. Estimated completion is 2024-02-02.
Who is sponsoring clinical trial NCT02990520?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia